LOC728699 Inhibitors
LOC728699 inhibitors like Rapamycin and Bortezomib disrupt core cellular processes such as growth, proliferation, and protein degradation, which could indirectly affect the activity of LOC728699 if it is involved in these processes. Kinase inhibitors, such as Staurosporine and PD98059, target the catalytic activity of kinases, potentially altering signaling cascades and cellular responses in which LOC728699 may play a part. Agents like Thapsigargin, 2-Deoxy-D-glucose, and Cycloheximide impact intracellular calcium levels, energy metabolism, and protein synthesis, respectively. Their actions could create an environment that influences LOC728699's stability or modulates its interactions with other cellular components.
Chloroquine and LY294002 represent molecules that interfere with autophagy and phosphoinositide 3-kinase (PI3K) signaling. The former could affect the turnover of cellular components, including LOC728699, while the latter might alter cell survival and growth signals. WZ4003 and KN-93 are more targeted in their effects, focusing on specific kinase families and calcium signaling. Their inhibition can lead to changes in metabolic and stress response pathways, as well as calcium-dependent processes, that might involve LOC728699.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR pathway, which can regulate cell growth and proliferation, potentially affecting LOC728699's function if it is related to these cellular processes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
General kinase inhibitor, can inhibit a wide range of protein kinases, potentially impacting signaling pathways involving LOC728699. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, can lead to increased levels of ubiquitinated proteins, potentially affecting cellular processes associated with LOC728699. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor, leads to increased cytosolic calcium levels, which may influence signaling pathways that LOC728699 is part of. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, which can prevent the activation of the ERK pathway, potentially affecting downstream effects mediated by LOC728699. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Glycolysis inhibitor, can impact energy metabolism, potentially affecting processes that LOC728699 is involved in. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis by interfering with the translocation step in protein synthesis, potentially affecting the expression and function of LOC728699. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Lysosomotropic agent, can inhibit autophagy by preventing lysosomal acidification, potentially impacting LOC728699 if it is involved in autophagic processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, can disrupt AKT signaling and affect various cellular functions that might be regulated by LOC728699. | ||||||
WZ4003 | 1214265-58-3 | sc-473979 | 5 mg | $300.00 | ||
NUAK family kinase inhibitor, can influence cellular metabolism and stress responses that LOC728699 might be involved in. | ||||||